Cognitive Function News and Research

Cognition is a concept used in different ways by different disciplines, but is generally accepted to mean the process of thought. For example, in psychology and cognitive science it refers to an information processing view of an individual's psychological functions.

A study by the UPV/EHU has assessed the effectiveness of various drugs, which are used to delay cognitive deterioration in patients with Alzheimer's, in improving cognitive impairment displayed by patients with schizophrenia.

Patients with high blood pressure and progression of periventricular white matter hyperintensities showed signs of cognitive impairment despite taking medication to lower their blood pressure, according to new research in the American Heart Association's journal Hypertension.

Researchers at Children's Hospital of Philadelphia evaluated a digital medicine tool designed as an investigational treatment for children with autism spectrum disorder and co-occurring attention/deficit-hyperactivity disorder.

Aerobic exercise can improve the size and function of the brain, and now investigators want to know if it can also improve cognitive function in patients with schizophrenia who struggle with memory and attention problems.

Boys with good motor skills are better problem-solvers than their less skillful peers, a new study from Finland shows. In contrast to previous studies, the researchers found no association between aerobic fitness or overweight and obesity with cognitive function in boys.

There's a reason so many children are prescribed methylphenidate, better known by the trade name Ritalin: it helps kids quell attention and hyperactivity problems and sit still enough to focus on a school lesson.

Thousands of Australians can take heart as new research from the University of South Australia shows a dairy-enhanced Mediterranean diet will significantly increase health outcomes for those at risk of cardiovascular disease – and it’s even more effective than a low-fat diet.

Disorders of sleep are some of the most common problems experienced by patients after traumatic brain injury. It is important to recognize and treat these problems early to allow for optimal cognitive recovery, but because they are so common, the importance of treating them is often underestimated.

A scientific strategy that explores therapeutic targets based on the biology of aging is gaining ground as an effective approach to prevent and treat Alzheimer's disease, according to research published in the December 7, 2018 online issue of Neurology.

Researchers at the University of Maryland School of Medicine's Maryland Psychiatric Center and Institute for Genome Sciences, along with researchers at the University of Maryland School of Pharmacy, have been awarded a collaborative five-year $1.78 million grant to study the brain-to-gut connection in schizophrenia.

Cancer treatments are suspected to accelerate certain aging processes in the body. A new study has found that indicators of such biological aging correlate with declines in cognitive function in women who had undergone breast cancer treatment several years earlier.

Taking typical daily annoyances such as a long wait at the doctor's office or a traffic jam on the freeway in stride may help preserve brain health in older adults, while emotional reactions could contribute to declines in cognition, a new study from Oregon State University has found.

Age-related declines in abstract reasoning ability predict increasing depressive symptoms in subsequent years, according to data from a longitudinal study of older adults in Scotland. The research is published in Psychological Science, a journal of the Association for Psychological Science.

A research team led by Dr. Kim Innes, a professor in the West Virginia University School of Public Health, has found that a simple meditation or music listening program may alter certain biomarkers of cellular aging and Alzheimer's Disease in older adults who are experiencing memory loss.

Researchers have shown that early dementia signs could be detected by a simple short scan of the individual’s neck. The actual dementia symptoms could be seen up to 10 years after these signs are visible on the scans they add. If proven robust for all cases, this test could soon become routine for screening middle aged individuals and classifying them as high risk for dementia later in life.

Pfizer Inc. today announced that the U.S. Food and Drug Administration has approved LORBRENA, a third-generation anaplastic lymphoma kinase tyrosine kinase inhibitor for patients with ALK-positive metastatic non-small cell lung cancer whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease; or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

In this interview, AZoNetwork speaks to Knauer about the use of FPLC for purification of proteins and
how their products enable scientists to get the most of liquid chromatography; conducted by Matthew Rafferty

Other Useful Links

News-Medical.Net provides this medical information service in accordance
with these terms and conditions.
Please note that medical information found
on this website is designed to support, not to replace the relationship
between patient and physician/doctor and the medical advice they may provide.

By continuing to browse or by clicking "Accept All Cookies," you agree to the storing of first and third-party cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Find out more.